Mylan n.v. (MYL)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities:
Net earnings (loss)

62

16

47

34

240

352

545

457

716

696

869

661

532

480

257

805

805

847

843

914

873

933

0

0

0

Adjustments to reconcile net (loss) earnings to net cash provided by (used in) operating activities:
Depreciation and amortization

1,933

2,019

2,080

2,111

2,111

2,109

2,027

1,969

1,888

1,805

1,756

1,759

1,641

1,523

1,387

1,198

1,154

1,032

859

735

606

566

0

0

0

Share-based Compensation

58

56

56

10

-6

-3

1

53

73

74

82

79

85

88

97

94

84

92

84

83

85

66

0

0

0

Change in estimated sales allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Deferred income tax (benefit) expense

-243

-192

-272

-256

-273

-264

-278

-46

-131

-111

-235

-647

-612

-609

-410

-131

-90

-115

-126

-298

-294

-315

0

0

0

Loss from equity method investments

-62

-62

-63

-65

-72

-78

-39

-49

-47

-58

-104

-111

-115

-112

-113

-111

-111

-105

-103

-98

-93

-91

0

0

0

Other non-cash items

-391

-360

-172

-88

-245

-286

-233

-378

-200

-261

-538

-558

-517

-499

-283

-205

-297

-263

-225

-174

-135

-139

0

0

0

Litigation settlements and other contingencies, net

0

11

-22

-15

51

31

35

21

32

40

6

-553

-606

-597

-554

-0

2

-15

20

2

-22

-7

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

9

20

-57

-60

-32

-340

116

85

78

162

98

-371

-71

131

-303

-99

227

-65

-53

116

-96

231

0

0

0

Inventories

461

512

599

593

573

547

467

270

181

129

30

183

162

279

368

324

406

320

272

200

196

147

0

0

0

Accounts payable

-19

-96

151

279

35

220

187

180

164

14

-54

-70

-97

87

-155

-83

90

131

369

76

17

-0

0

0

0

Income taxes

282

57

13

4

-81

-23

67

-69

34

15

-163

-19

-52

37

65

5

-45

-164

-130

-63

-91

78

0

0

0

Other operating assets and liabilities, net

-78

-63

41

-97

74

177

6

501

471

420

843

647

389

523

41

77

48

44

43

116

202

173

0

0

0

Net cash provided by (used in) operating activities

2,134

1,803

1,753

1,918

1,680

2,341

2,201

2,096

2,233

2,064

1,918

2,570

2,419

2,047

2,349

2,123

1,822

2,008

1,483

949

1,013

1,014

0

0

0

Cash flows from investing activities:
Cash paid for acquisitions, net

141

148

-92

9

9

65

402

158

158

167

401

5,610

6,553

6,481

0

0

0

-

-

-

-

-

-

-

-

Capital expenditures

203

213

254

273

274

252

256

242

248

275

307

378

397

390

395

361

366

362

312

294

301

325

0

0

0

Proceeds from sale of assets and subsidiaries

-

-

-

-

-

-

-

-

-

86

31

31

31

0

0

0

0

-

-

-

-

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Purchase of available for sale securities and other investments

71

25

33

31

63

63

137

134

101

96

16

19

24

30

25

27

30

62

61

61

55

19

0

0

0

Proceeds from the sale of marketable securities

37

27

32

32

77

85

159

155

109

96

14

16

17

21

19

22

26

33

33

34

27

20

0

0

0

Payments for product rights and other, net

244

192

477

458

616

943

674

755

884

620

722

659

332

360

274

581

600

506

394

389

302

420

0

0

0

Proceeds from the sale of assets

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-595

-525

-586

-711

-857

-1,210

-1,255

-1,080

-1,228

-976

-1,351

-7,005

-7,694

-7,677

-8,012

-2,603

-1,642

-1,569

-722

-748

-686

-800

0

0

0

Cash flows from financing activities:
Proceeds from issuance of long-term debt

40

7

6

6

2,079

2,577

2,898

2,897

1,374

876

0

0

0

-

-

-

-

3,539

3,990

2,300

2,135

2,235

0

0

0

Payments of long-term debt

1,141

1,108

1,223

1,122

2,667

3,165

3,084

3,504

2,180

2,232

6,976

7,122

6,846

6,296

1,217

4,010

4,384

4,484

5,934

2,969

2,135

2,295

0

0

0

Treasury Stock, Value, Acquired, Cost Method

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in short-term borrowings, net

-0

-1

-0

-199

-355

-44

-0

218

323

-2

-56

-56

-41

40

49

-380

-102

-329

-362

191

-198

-107

0

0

0

Taxes paid related to net share settlement of equity awards

6

8

8

8

8

10

10

10

10

7

12

12

16

17

13

12

7

31

36

36

37

27

0

0

0

Contingent consideration payments

47

60

59

50

43

11

16

16

22

26

30

30

39

35

0

0

0

-

-

-

-

-

-

-

-

Payments of financing fees

1

3

3

5

22

21

22

20

6

10

26

28

84

112

111

139

139

130

118

86

25

5

0

0

0

Payments for Repurchase of Common Stock

-

-

-

-

-

-

-

-

932

500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

6

8

10

8

9

17

20

22

23

17

15

15

15

13

16

18

33

97

112

110

99

53

0

0

0

Other items, net

-2

-2

-1

-1

-1

-1

0

-0

-0

-0

-1

-0

1

0

3

4

12

51

58

57

51

30

0

0

0

Net cash used in financing activities

-1,153

-1,169

-1,280

-1,372

-1,009

-1,090

-1,153

-1,352

-1,438

-1,893

-1,298

-1,406

4,738

5,344

6,312

6,411

744

604

-332

73

-261

-267

0

0

0

Effect on cash of changes in exchange rates

-28

-7

-14

-5

-27

-21

-39

-28

19

27

19

21

-9

-9

19

-10

-1

-33

-40

-27

-31

-12

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

357

101

-128

-171

-214

19

-247

-364

-414

-777

-712

-5,819

-546

-295

669

5,922

922

1,010

387

245

34

-65

0

0

0

Supplemental disclosures of cash flow information —
Cash paid during the period for:
Ordinary shares issued for acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,305

6,305

-

0

0

0